What companies are HELX's competitors?

Franklin Genomic Advancements ETF (HELX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does HELX compare to its peers?

The peer comparison table on this page shows Franklin Genomic Advancements ETF (HELX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does HELX operate in?

Franklin Genomic Advancements ETF (HELX) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

HELX

Franklin Genomic Advancements ETF

CBOE·Asset Management · Financial Services

$41.54$0.06−0.14%

Pre-market·$41.59+0.14%

Market cap$31.15M·Market closed·Sep 15 3:59 PM UTC

Frequently Asked Questions About HELX

What companies are HELX's competitors?: Franklin Genomic Advancements ETF (HELX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does HELX compare to its peers?: The peer comparison table on this page shows Franklin Genomic Advancements ETF (HELX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does HELX operate in?: Franklin Genomic Advancements ETF (HELX) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

HELX

Franklin Genomic Advancements ETF

CBOE·Asset Management · Financial Services

$41.54$0.06−0.14%

Pre-market·$41.59+0.14%

Market cap$31.15M·Market closed·Sep 15 3:59 PM UTC

Peers


BYRE	Principal Real Estate Active Opportunities ETF	$26.56	$24.6M
BWTG	Brendan Wood TopGun ETF	$41.34	$21.1M
MEDX	Horizon Kinetics Medical ETF	$35.29	$19.3M
FMKT	The Free Markets ETF	$22.25	$19.2M
RHRX	RH Tactical Rotation ETF	$21.42	$17.6M
RW	Rainwater Equity ETF	$24.62	$17.2M
XTJL	Innovator U.S. Equity Accelerated Plus ETF - July	$42.16	$17.1M
QRMI	Global X - Nasdaq 100 Risk Managed Income ETF	$15.22	$16.1M
DGIN	VanEck Digital India ETF	$37.02	$15.2M
UCC	ProShares - Ultra Consumer Discretionary	$43.58	$10.1M

Frequently Asked Questions About HELX

What companies are HELX's competitors?: Franklin Genomic Advancements ETF (HELX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does HELX compare to its peers?: The peer comparison table on this page shows Franklin Genomic Advancements ETF (HELX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does HELX operate in?: Franklin Genomic Advancements ETF (HELX) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.